Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00127647
Status:
COMPLETED
Last Update Posted:
2022-02-14
First Post:
2005-08-04
Brief Title:
An Approved Drug to Study a New Indication for Allergic Rhinitis 0476-327
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
MK0476 Phase III Double-Blind Comparative Study - Allergic Rhinitis
Status:
COMPLETED
Status Verified Date:
2022-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this trial is to evaluate the efficacy and safety of an investigational drug in adult patients with allergic rhinitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_038 | None | None | None |
| MK0476-327 | None | None | None |